Psoriasis Club
  • Forum
  • Home
  • Portal
  • Member List
  • Psoriasis Score
  • PQOLS
  • What is psoriasis
  • Search
  • Help
Hello Guest, Welcome To The Psoriasis Club Forum. We are a self funded friendly group of people who understand.
Never be alone with psoriasis, come and join us. (Members see a lot more than you)
wave
Login Register
Login
Username:
Password:
Lost Password?
 
Psoriasis Club › HealthHealth Boards › Psoriasis In The News v
« Previous 1 … 15 16 17 18 19 … 55 Next »

Methorexate drug survival rate is low in psoriasis patients

Linear Mode
Methorexate drug survival rate is low in psoriasis patients
Turnedlight Offline
100 + Member I Just Cant Stop !

100 + Member I Just Cant Stop !
Posts: 6,178
Threads: 62
Joined: Apr 2015
Gender: Female
Location: Uk
Treatment: Skyrizi
#15
Fri-27-07-2018, 13:32 PM
(Thu-26-07-2018, 18:34 PM)Moxtina Wrote: Just to chime in, a bit late to the game, I think....

if you have the MTHFR genetic polymorphism, you should NEVER take methotrexate. An estimated 30-60% of the population has this folate absorption/methylation disorder and many do not even know it. There's a strong intersection between autoimmune disease and MTHFR. I recently had the test done and found that I was positive for the condition and that it explains a lot of my health issues. If you have the means, do it!

Those with MTHFR have varying degrees of problems metabolizing folate. Methotrexate works by interfering with the body's use of folate (or, as you might know it, folic acid - the synthetic, cheaper, more popular version of FOLATE) a nutrient needed for cell growth. This causes problems, as you might imagine! We need ALL the B vitamins to live.

Methotrexate can cause serious issues, or simply fail to be effective (on the less extreme side), especially in those with the MTHFR C677T polymorphism. There is increased risk of MTX-induced hepatic and gastrointestinal toxicities and increased risk of severe mucositis and hematological toxicity. According to one paper I read on the topic, the MTHFR A1298C polymorphism was *not significantly associated with hepatic and hematological toxicity, however, the MTHFR C677T polymorphism is correlated with MTX toxicity via blood and other types of cancers.

There are some great websites that discuss this genetic issue and many articles from studies done on the effects of MTX/MTHFR.

Moxie

I presume that’s why you always take folic acid alongside mtx?

We do not get that kind of diagnostic test as standard but if it was that dangerous for a certain portion of the population to take mtx, I imagine they just wouldn’t risk it.

As it is on the NHS, we try things out, if they work and we’re happy then all good, if they don’t work or we have side effects, we move on. I imagine this approach is (currently) cheaper than gene profiling.
Quote
« Next Oldest | Next Newest »


Messages In This Thread
Methorexate drug survival rate is low in psoriasis patients - by Fred - Fri-18-08-2017, 19:26 PM
RE: Methorexate drug survival rate is low in psoriasis patients - by jiml - Fri-18-08-2017, 19:40 PM
RE: Methorexate drug survival rate is low in psoriasis patients - by Fred - Fri-18-08-2017, 19:57 PM
RE: Methorexate drug survival rate is low in psoriasis patients - by mataribot - Fri-18-08-2017, 21:06 PM
RE: Methorexate drug survival rate is low in psoriasis patients - by Caroline - Fri-18-08-2017, 21:29 PM
RE: Methorexate drug survival rate is low in psoriasis patients - by D Foster - Sat-19-08-2017, 15:49 PM
RE: Methorexate drug survival rate is low in psoriasis patients - by Fred - Sat-19-08-2017, 15:53 PM
RE: Methorexate drug survival rate is low in psoriasis patients - by D Foster - Sat-19-08-2017, 16:00 PM
RE: Methorexate drug survival rate is low in psoriasis patients - by mataribot - Sat-19-08-2017, 16:11 PM
RE: Methorexate drug survival rate is low in psoriasis patients - by Turnedlight - Sat-19-08-2017, 19:38 PM
RE: Methorexate drug survival rate is low in psoriasis patients - by tdjclarke - Sun-13-05-2018, 13:12 PM
RE: Methorexate drug survival rate is low in psoriasis patients - by Fred - Sun-13-05-2018, 13:18 PM
RE: Methorexate drug survival rate is low in psoriasis patients - by jiml - Sun-13-05-2018, 13:24 PM
RE: Methorexate drug survival rate is low in psoriasis patients - by Moxtina - Thu-26-07-2018, 18:34 PM
RE: Methorexate drug survival rate is low in psoriasis patients - by Turnedlight - Fri-27-07-2018, 13:32 PM

Possibly Related Threads…
Thread Author Replies Views Last Post
News Drug survival for methotrexate in psoriasis patients Fred 7 7,293 Fri-21-05-2021, 14:44 PM
Last Post: D Foster
News Patients on bio's for psoriasis have low hospitalization risk with covid Fred 16 13,428 Sun-29-11-2020, 09:11 AM
Last Post: KatT
News Otezla effectiveness, safety, and drug survival study Fred 0 2,002 Fri-10-04-2020, 12:27 PM
Last Post: Fred
News Rate of tattoo complications in psoriasis patients low Fred 7 6,805 Thu-03-10-2019, 00:22 AM
Last Post: KatT
News Cosentyx shows low immunogenicity in psoriasis patients treated up to 5 years Fred 5 5,352 Wed-24-04-2019, 13:22 PM
Last Post: Fred



Users browsing this thread:
    About | Contact us | Login | Register | Home | Cookies/GDPR | RSS Syndication | Portal | Types Of Psoriasis | Psoriasis Score | Members Only Boards
    Copyright © 2010 - 2025 Psoriasis Club | All Rights Reserved | Founded May 2010 | Psoriasis Club Is Self Funded Without Sponsors Or Donations | Software by MyBB | Social
Linear Mode
Threaded Mode